Next we performed dose titration experiments using three CRC cell lines with high, intermediate, and low CD133 surface antigen densities (Caco-2, CD133high; HCT-116, CD133int; HT-29, CD133low). The gene discussed is PROM1; the disease is colorectal carcinoma.